163 results on '"di Grazia, C."'
Search Results
2. Hepatitis B reactivation in HBsAg-negative/HBcAb-positive allogeneic haematopoietic stem cell transplant recipients: risk factors and outcome
3. DLI after haploidentical BMT with post-transplant CY
4. Unmanipulated haploidentical bone marrow transplantation and post-transplant cyclophosphamide for hematologic malignanices following a myeloablative conditioning: an update
5. DISCONTINUING IMMUNOSUPPRESSIVE THERAPY FOLLOWING AN ALLOGENEIC HEMOPOIETIC STEM CELL TRANSPLANT (HSCT):A CROSS SECTIONAL ANALYSIS OF 799 PATIENTS, 1 YEAR POST TRANSPLANT: PH-P337
6. UNMANIPULATED HAPLOIDENTICAL TRANSPLANTS FOR ACUTE MYELOID LEUKEMIA (AML) AND REFRACTORY ANEMIA WITH EXCESS BLASTS (RAEB): PH-O126
7. PRE-ENGRAFTMENT BLOODSTREAM INFECTIONS IN 489 HAEMATOPOIETIC STEM CELL TRANSPLANT RECIPIENTS: AETIOLOGY, RISK FACTORS AND IMPACT ON MORTALITY.: PH-O023
8. ALLOGENEIC TRANSPLANTS FOR MYELODISPLASTIC SYNDROMES: STRONG REDUCTION OF TRANSPLANT MORTALITY IN RECENT YEARS: PH-O013
9. Extracorporeal photopheresis for the treatment of steroid refractory acute GVHD
10. Assessment of orbital volume and morphological changes after rapid maxillary expansion performed with tooth-bone and bone-borne devices. A retrospective study using surface-to surface matching technique
11. Enhancing the diagnosis of maxillary transverse discrepancy through 3-D technology and surface-to-surface superimposition. Description of the digital workflow with a documented case report
12. Factors predicting response and graft-versus-host disease after donor lymphocyte infusions: a study on 593 infusions
13. Unmanipulated haploidentical transplants compared with other alternative donors and matched sibling grafts: a single Center experience in 488 patients: O383
14. Anti-CD26 monoclonal antibody for the treatment of steroidrefractory acute graft-versus-host disease (SR-GvHD): a report of two prospective studies: O159
15. Allogeneic bone marrow transplantation (BMT) for adults with acute lymphoblastic leukemia (ALL): predictive role of minimal residual disease monitoring on relapse
16. Serum cholinesterase is an early and sensitive marker of graft-versus host-disease (GVHD) and transplant-related mortality (TRM)
17. Pre-emptive therapy of acute graft-versus-host disease: a pilot study with antithymocyte globulin (ATG)
18. Risk factors for non-relapse mortality in 287 patients receiving 1288 donor lymphocyte infusions: P1046
19. Post-transplant CMV reactivation after CBT: the role of delayed immune reconstitution or donorʼs seronegativity?: P756
20. Acute graft-versus-host disease II-IV in 1465 patients: has outcome improved over the past two decades?: O386
21. Thiotepa-based reduced intensity conditioning regimen: a 10 year follow up
22. Successful non-invasive management of late-onset haemorrhagic cystitis in intrabone cord blood transplant recipients
23. Acute disseminated encephalomyelitis after allogenic bone marrow transplantation. Report of two cases
24. Invasive aspergillosis in allogeneic stem cell transplant recipients from alternative donor: incidence, risk factors and outcome
25. Immune reconstitution after cord blood transplantation by direct intrabone injection of cells
26. Allogeneic hemopoietic stem cell transplants for patients with relapsed acute leukemia: long-term outcome
27. Reduction of transplant related mortality with time: major improvement for patients allografted with early disease
28. Molecular relapse of acute lymphoblastic leukaemia after allogeneic haematopoietic stem cell transplantation can be successfully treated with donor lymphocyte infusions
29. Vincristine as salvage treatment for refractory thrombotic thrombocytopenic purpura
30. S1624 A DAY 100 LAB-SCORE PREDICTS EXTENSIVE CGVHD, OVERALL SURVIVAL AND TRANSPLANT-RELATED MORTALITY AFTER HEMATOPOIETIC STEM CELL TRANSPLANTATION: FINAL ANALYSIS
31. Serial monitoring of isavuconazole blood levels during prolonged antifungal therapy
32. Prophylactic antithymocyte globulin reduces the risk of chronic graft-versus-host disease in alternative-donor bone marrow transplants
33. Small bowel intussussception due to metastatic melanoma of unknown primary site. Case report
34. Biliodigestive fistulae and gallstone ileus;diagnostic and therapeutic considerations. Our experience
35. Risk management in surgery
36. DLI after haploidentical BMT with post-transplant CY
37. Allogeneic bone marrow transplantation (BMT) for adults with acute lymphoblastic leukemia (ALL): predictive role of minimal residual disease monitoring on relapse
38. (1-3)- -D-Glucan in Cerebrospinal Fluid Is Useful for the Diagnosis of Central Nervous System Fungal Infections
39. Subcutaneous low-dose IL-2 for remission maintenance in elderly acute myeloid leukemia patients
40. Leukemia Relapse after Allogeneic Transplants in AML: Predictive Role of WT1 Expression and Protective Effect of DLI.
41. C032 Allogeneic hemopoietic stem cell transplantation for patients with myelodysplastic syndrome: the effect of blast count and disease status at transplant
42. 224: Thiotepa based conditioning regimen in 374 patients undergoing allogeneic stem cell transplants from related or unrelated donors
43. Biliodigestive fistulae and gallstone ileus: diagnostic and therapeutic considerations. Our experience.
44. Single-incision laparoscopic appendectomy is comparable to conventional laparoscopic and laparotomic appendectomy: our single center single surgeon experience.
45. Technique and outcomes about a new laparoscopic procedure: the Pelvic Organ Prolapse Suspension (POPS).
46. Cholecystectomy by single incision laparoscopic surgery (SILS): early experience and technique standardization.
47. Real-World Validation of Molecular International Prognostic Scoring System for Myelodysplastic Syndromes
48. Treatment of steroid resistant acute graft versus host disease with an anti-CD26 monoclonal antibody-Begelomab
49. Extracorporeal photopheresis for the treatment of steroid refractory acute GVHD
50. Busulfan-fludarabine versus busulfan-cyclophosphamide for allogeneic transplant in acute myeloid leukemia: long term analysis of GITMO AML-R2 trial.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.